Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intravenous Immunoglobulin”

464 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 464 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07231523
What this trial is testing

EFG vs IVIG in TAMG

Who this might be right for
EfgartigimodIntravenous ImmunoglobulinMyasthenia Gravis Associated With Thymoma
Shanghai Zhongshan Hospital 64
Early research (Phase 1)Study completedNCT00016237
What this trial is testing

Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Bladder CancerKidney CancerLung Cancer
EMD Serono
Early research (Phase 1)Study completedNCT00006009
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Stanford University
Large-scale testing (Phase 3)Study completedNCT01458171
What this trial is testing

Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Who this might be right for
Primary Immune Deficiency Disorder
CSL Behring 23
Large-scale testing (Phase 3)Study completedNCT02810444
What this trial is testing

Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID

Who this might be right for
Primary Immunodeficiency Disease
Biotest 81
Early research (Phase 1)Study completedNCT01803867
What this trial is testing

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Acorda Therapeutics 72
Early research (Phase 1)Study completedNCT01125631
What this trial is testing

Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 8
Testing effectiveness (Phase 2)Study completedNCT00073047
What this trial is testing

Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis

Who this might be right for
Ulcerative ColitisGastrointestinal DiseaseInflammatory Bowel Disease
Facet Biotech 150
Testing effectiveness (Phase 2)Ended earlyNCT00299988
What this trial is testing

Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Weill Medical College of Cornell University 24
Early research (Phase 1)Study completedNCT00138411
What this trial is testing

Monoclonal Antibody for Treatment of Inhalation Anthrax

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableStudy completedNCT03967899
What this trial is testing

Study of Electrical Prognostic Factors of Response to Intravenous Immunoglobulin Treatment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Who this might be right for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Fondation Hôpital Saint-Joseph 42
Large-scale testing (Phase 3)Study completedNCT00430105
What this trial is testing

Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides

Who this might be right for
ANCA Associated Systemic VasculitisWegener's GranulomatosisMicroscopic Polyangiitis
Cambridge University Hospitals NHS Foundation Trust 160
Large-scale testing (Phase 3)Study completedNCT00157079
What this trial is testing

Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders

Who this might be right for
Primary Immunodeficiency Diseases (PID)Immune Thrombocytopenic Purpura (ITP)Kawasaki Syndrome
Baxalta now part of Shire 61
Post-approval studies (Phase 4)Study completedNCT03033745
What this trial is testing

Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiency
CSL Behring 49
Large-scale testing (Phase 3)WithdrawnNCT03749096
What this trial is testing

Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person Syndrome

Who this might be right for
Stiff-Person Syndrome
Mayo Clinic
Testing effectiveness (Phase 2)Ended earlyNCT00000961
What this trial is testing

The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 112
Testing effectiveness (Phase 2)UnknownNCT06159283
What this trial is testing

Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment

Who this might be right for
COVID-19
Jaehoon Ko 58
Large-scale testing (Phase 3)Study completedNCT04558918
What this trial is testing

Study of Efficacy and Safety of Twice Daily Oral LNP023 in Adult PNH Patients With Residual Anemia Despite Anti-C5 Antibody Treatment

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Novartis Pharmaceuticals 97
Testing effectiveness (Phase 2)UnknownNCT02782897
What this trial is testing

Intravenous Immunoglobulin for Acute Intracranial Hemorrhage

Who this might be right for
Intracranial Hemorrhage, Hypertensive
Wei Wang 60
Large-scale testing (Phase 3)Study completedNCT01408550
What this trial is testing

Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids

Who this might be right for
Bullous Pemphigoid
Nihon Pharmaceutical Co., Ltd 56
Next Page